Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease - 27/05/22
Abstract |
The coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, is a current pandemic that has resulted in nearly 250 million cases and over 5 million deaths. While vaccines have been developed to prevent infection, and most COVID-19 cases end up being fairly light, there are severe cases of COVID-19 that may end up in death, even with adequate healthcare treatment. New options to combat this disease’s effects, therefore, could prove to be invaluable in saving lives. Adamalysins are proteins that have several roles in regulating different functions in the human body but are also known to have functions in inflammation. They are also known to have roles in several different diseases, including COVID-19, where ADAM17, in particular, is now well-known to have a prominent role, but also several diseases which include comorbidities that may worsen cases of COVID-19. Therefore, investigating the functions of adamalysins in disease may give us clues to the molecular workings of COVID-19 as well as potentially new therapeutic targets. Understanding these molecular mechanisms may also allow for an understanding of the mechanisms behind the rare severe side effects that occur in response to current COVID-19 vaccines, which may lead to better monitoring measures for people who may be more at risk of developing these side effects. This review investigates the known roles and functions of adamalysins in disease, including what is currently known of their involvement in COVID-19, and how these functions might be involved.
Il testo completo di questo articolo è disponibile in PDF.Graphical Abstract |
Highlights |
• | New COVID-19 therapies are still needed, especially for severe cases. |
• | Adamalysins have been found to be involved in COVID-19 pathogenesis. |
• | Known adamalysins involved include ADAM17, ADAM12 and ADAMTS13. |
• | They play roles in virus entry into cells, inflammation, fibrosis, thrombosis, etc. |
• | Other adamalysins that contribute to similar pathogenesis could also be involved in COVID-19. |
Keywords : SARS-CoV-2, COVID-19, Inflammation, ADAM, ADAMTS, ADAMTSL
Mappa
Vol 150
Articolo 112970- Giugno 2022 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.